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Use of Enhanced Recovery After Surgery (ERAS) Protocol for Immediate Sub-Muscular Breast 
Reconstruction after Outpatient Mastectomy is Safe and Significantly Reduces Costs 
Ryan Kunkel, MD; Audrey Rich, PA-C; Venus Barlas, MS; Stephanie Fine, MD
Department of Surgery, Division of Plastic and Reconstructive Surgery, University of New Mexico Health Sciences Center
● ERAS protocols are associated with decreased postoperative stays, reduced 
opioid use, lower rates of postoperative nausea and vomiting, and lower overall 
costs to institutions and healthcare systems1-4
● The aim of this study was to evaluate the impact of an ERAS approach on 
mastectomy with implant-based subpectoral reconstruction (IBR) with respect 
to procedure cost and 30-day complication rates for both ambulatory surgery 
patients and patients hospitalized overnight
Study Type: Retrospective chart review analysis
Subjects: Patients over age 18 undergoing nipple-sparing mastectomy or skin-
sparing mastectomy with subpectoral IBR at a single institution.
Study Cohorts: 
● ERAS: same-day surgery at an ambulatory surgical center
● Overnight hospital admission control group
● Surgeries performed by 2 breast surgeons and 3 plastic surgeons
Analysis Plan:
● ERAS compared to control group, divided by surgical modality (nipple sparing 
vs. non-nipple sparing mastectomy)
● Demographics, comorbidities, 30-day complications, and cost analyses were 
examined.
● Direct costs were defined as patient-specific costs, such as pharmacy costs, 
and radiology charges. Indirect costs included a facility-derived multiplier 
added to the encounter to cover fixed expenses such as salaried labor, and 
building overhead. 
Introduction
Conclusions
Methods
Results
Table 1. Descriptive characteristics of patients and surgery by type of stay, n (%)
Table 2. Direct and indirect costs ($) by type of stay and surgery type (n=68)
* The p-value is calculated by t-Test or ANOVA with multiple group comparisons
Type of Stay
Characteristic Level
ERAS
N=34
Overnight Stay
N=34
P-value*
Unilateral / Bilateral
Unilateral 17 (50) 17 (50)
1.000Bilateral 17 (50) 17 (50)
Length of Stay
Same day 34 (100) 0 (0)
<.0001
One night, OBS 0 (0) 30 (88.24)
2 Days 0 (0) 1 (2.94)
3+ Days 0 (0) 3 (8.82)
Complication
None 33 (97.06) 29 (85.29)
0.197Cellulitis 1 (2.94) 2 (5.88)
Hematoma 0 (0) 3 (8.82)
Indication
Malignant 12 (35.29) 15 (44.12)
0.400Prophylactic 12 (35.29) 7 (20.59)
Both 10 (29.41) 12 (35.29)
ER Visit (30d Post) 0 (0) 3 (8.82) 0.076
Diabetes 1 (2.94) 2 (5.88) 0.555
Obstructive Sleep Apnea 4 (11.76) 1 (2.94) 0.163
Social Issues 0 (0) 6 (17.65) 0.025
Subsequent Mastectomy 3 (8.82) 2 (5.88) 0.642
Age, mean (SD) 45.71 (10.74) 49.03 (10.47) 0.201
BMI (kg/m2), mean (SD) 25.22 (4.23) 27.79 (5.82) 0.041
PACU Time (min), mean (SD) 150.56 (54.35) 159.29 (103.27) 0.664
OR Time (min), mean (SD) 269.06 (77.87) 289.03 (75.05) 0.286
Stay N Mean (SD) 95% CI Mean P-Value*
Direct Cost ERAS 34 13791 (6243) 11613 15970 0.001
OVS 34 19274 (6858) 16881 21666
Indirect Cost ERAS 34 1882 (810) 1600 2165 0.001
OVS 34 3511 (2623) 2595 4426
Direct Cost Unilateral 34 13096 (4665) 11468 14723 <.0001
Bilateral 34 19969 (7442) 17372 22566
Indirect Cost Unilateral 34 2367 (1804) 1737 2996 0.196
Bilateral 34 3026 (2329) 2214 3839
Direct Cost
Bilateral + ERAS 17 16716 (7027) 13103 20329
<.0001
Bilateral + OVS 17 23222 (6510) 19875 26569
Unilateral + ERAS 17 10866 (3582) 9024 12708
Unilateral + OVS 17 15325 (4637) 12941 17709
Indirect Cost
Bilateral + ERAS 17 2226 (911) 1757 2694
0.005
Bilateral + OVS 17 3827 (2999) 2285 5369
Unilateral + ERAS 17 1539 (524) 1270 1808
Unilateral + OVS 17 3194 (2233) 2046 4342
● There were no significant differences in 30-day complication rates between 
patients whose mastectomy with reconstruction procedure was at an ambulatory 
surgical center (utilizing our ERAS protocol) and patients whose operation was 
at a hospital facility with a planned overnight admission. 
● Social factors were the main determinant for identifying those patients who 
could be safely discharged from an ambulatory setting from those requiring a 
planned admission. 
● On average, a 30% cost saving can be expected with the application of ERAS 
principles and a same-day surgery approach. 
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Figure 1. Direct and indirect cost ($) by type of stay and surgery type (n=68)
Pre-operative
Analgesia
• Acetaminophen 1000 
mg PO
• Gabapentin 600 mg 
PO
• Celecoxib 200 mg 
PO
NPO status
• Gatorade up to 2 
hours prior to start 
time
PONV Prophylaxis
Regional anesthesia
• Pecs II block: 20 cc 
of 0.25% 
bupivacaine with 
epinephrine
Anxiolysis
• Minimize long-acting 
sedatives (e.g. 
midazolam)
Intra-operative
Analgesia
• Fentanyl/ 
hydromorphone 
for patients 
without pecs 
block
PONV Prophylaxis
• Dexamethasone 
4 mg IV on 
induction
• Ondansetron 4 
mg IV prior to 
emergence
• Consider TIVA if 
Apfel risk 
score=4
Post-operative
Analgesia
• IV 
hydromorphone 
bolus for severe 
pain
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acetaminophen 
or oxycodone/ 
acetaminophen 
PO q 6-8 hrs
PRN for 
moderate pain
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